Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
GLP-1RAs are highly effective medications used to treat T2D and obesity while simultaneously conferring protection against cardiovascular disease, kidney disease, and hepatic steatosis in these patients
Laron Z
Background diabetes therapy included metformin and sodium-glucose transporter-2 inhibitor (SGLT2i) in 73 Percentage and 27 Percentage of patients, respectively [10]
Acid reflux, stomach pain, vomiting, and diarrhea are also potential side effects
It is important to understand that while improving gut barrier function is increasingly used in the clinical setting as a therapeutic goal, the evidence is not yet there to support the efficacy of a single intervention in curing a disease by restoring or improving barrier function
